LogicMark, Inc.

LGMK ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $11.4M $9.9M $9.9M $11.9M $10.0M $11.4M $17.1M $17.1M
Cost of Revenue $3.8M $3.3M $3.3M $4.7M $4.2M $3.2M $4.4M $4.8M
Gross Profit $7.6M $6.6M $6.7M $7.2M $5.8M $7.7M $12.8M $12.3M
Gross Margin 66.8% 66.8% 67.1% 60.7% 57.7% 67.1% 74.5% 71.9%
Operating Expenses
Research & Development $617.4K $558.6K $982.7K $1.2M $932.6K $1.1M $1.2M $761.7K
SG&A Expense $7.9M $7.6M $8.5M $9.0M $5.8M $5.3M $5.7M $6.9M
Operating Income $-7.9M $-7.7M $-15.3M $-6.9M $-7.5M $-586.1K $2.6M $587.5K
Operating Margin -69.1% -77.5% -154.4% -58.0% -75.3% -5.1% 15.0% 3.4%
Interest Expense $1.4M $2.3M $3.0M $3.0M
Pretax Income $-7.5M $-9.0M $-14.9M $-6.8M $-11.5M $-2.8M $-2.7M $-1.3M
Income Tax Expense $14.9K $9.9K $-309.8K $138.0K $204.3K $24.9K $-332.6K $34.3K
Net Income $-7.5M $-9.0M $-14.6M $-6.9M $-11.7M $-2.9M $-11.8M $-7.1M
Net Margin -65.4% -90.9% -146.5% -58.1% -116.8% -25.0% -68.8% -41.4%
EPS (Basic) $-13.06 $-10,971.40 $-24.29 $-1.26 $-0.19 $-0.10 $-0.04 $-0.02
EPS (Diluted) $-13.06 $-10,971.40 $-24.29 $-1.26 $-0.19 $-0.01 $-0.04 $-0.02
Shares Outstanding (Basic) 594.9K 635.0K 649.6K 5.7M 75.7M 39.1M 360.6M 302.7M
Shares Outstanding (Diluted) 594.9K 635.0K 649.6K 5.7M 75.7M 39.1M 360.6M 302.7M
Dividends Per Share
← Newer Page 1 of 2 Older →